Bronwen E. Shaw

Sep 16, 2024 | medrxiv.org | Jason Dehn |Brent R. Logan |Bronwen E. Shaw |Steven M. Devine

S.J.L- Board of Directors, nmdp (uncompensated)A.S.-Consulting Fees: Sanofi and TherakosNCT03904134Support for this study was provided by grants #U10HL069294 and #U24HL138660 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute.

May 9, 2024 | medrxiv.org | Rodney A. Sparapani |Martin J. Maiers |Stephen Spellman |Bronwen E. Shaw

The authors have declared no competing interest. CIBMTR is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID); 75R60222C00011 from the Health Resources and Services Administration (HRSA); and N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research.